沙龙茶会 | 聚焦中国医疗健康市场投资机遇，启珂健康投资论坛开始征召演讲公司

近期中国政府陆续公布的重磅政策改革旨在支持和推进中国创新跨入国际舞台，在此背景下第十届启珂健康投资论坛（CHIC）将聚焦中国医疗健康市场最新的投资机遇。一如往常，启珂健康投资论坛还将为您带来顶尖风险资本、私募股权、公共股权投资者以及中外知名医疗健康企业的真知灼见。

申请在CHIC演讲，您将有机会在超过500位企业高管和投资者前分享您的故事。申请将在1月底截止，请尽快将英文的公司简历递交给我们：

[e-mail]

微信：dai-jialing

2019年3月26日至28日 - 上海

上海浦东丽思卡尔顿酒店

• Pharmaceuticals & Biotech

• Healthcare Services / Healthcare IT

• MedTech (Devices/Instruments/Diagnostics)

• Digital Health / A.I.

Companies at all stages are encouraged to apply to present, including start-ups, venture pre-profit, growth, and public companies.

Presentations may be given in English or Mandarin.

Applicants should include the following in your submission:

• Company name & general introduction

• Management team

• Brief history/business scope

• Company stage (start-up, venture pre-revenue, growth revenue stage, public)

• Current scale of revenue/profit (if applicable)

• Whether or not you are actively seeking funding

• Potential speakers

Applicants will be reviewed and judged by the CHIC Organizing Committee, composed of industry experts, experienced investors and successful entrepreneurs. Final presenting companies will be announced the week of February 1, 2019.

Please email your application to:

[e-mail]

Deadline to Submit: January 31, 2019

Hongbo Lu 

Partner, Lilly Asia Ventures 

Marietta Wu

Managing Director, Quan Capital

Frank Kung

Managing Partner, Vivo Capital

James Li

Chief Executive Officer, JW Therapeutics

Norman Chen

Venture Partner, 6 Dimensions Capital

来源：研发客

往期精选▼